However, for others, the increased phosphorylation must reflect a change in relative phosphorylation, as for Erbb3 in PyMT tumours, Cdk16 in p53 tumours and Erffi1 in HER2 tumours (Figure 2C to E). This evidence concerns the gene TP53 and neoplasm.